Multiple Synchronous Tumours: A Peculiar Clinical Case
- 1 Medical Oncology Department, IPO, Porto, Portugal
- 2 Medical Oncology Department, IPO, Porto, Portugal
- 3 Medical Oncology Department, IPO, Porto, Portugal
Abstract
Background : Due to improvements in diagnosis, the better outcomes of oncological patients and the increase in the average age, the incidence of synchronous tumours is likely to increase. Aim : To reflect on the challenges of a case with multiple integrated diagnostic and therapeutic approaches and to bring to consideration the increasing prevalence of similar situations. Case Presentation: In this clinical case, the authors describe the evolution of an asymptomatic patient with several synchronous tumours (a GEJ primary adenocarcinoma, a low grade urothelial carcinoma in situ , a localized squamous cell lung carcinoma and 2 IPMNs). Conclusion : The challenge of this case lies in the difficult diagnostic approach, the assembly of a multidisciplinary and time-sensitive treatment plan and the individualized follow-up, due to lack of guidelines. More research is needed in this area.
- Vogt, A., et al. (2017) Multiple Primary Tumours: Challenges and Approaches: A Review. ESMO Open, 2, e000172. https://doi.org/10.1136/esmoopen-2017-000172
- Testori, A., et al. (2015) Multiple Primary Synchronous Malignant Tumors. BMC Research Notes, 8, 730. https://doi.org/10.1186/s13104-015-1724-5
- Shapiro, J., et al. (2015) Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery Alone for Oesophageal or Junctional Cancer (CROSS): Long-Term Results of a Randomised Controlled Trial. The Lancet Oncology, 16, 1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6
- Al Batran, S.E., et al. (2019) Perioperative Chemotherapy with Fluorouracil plus Leucovorin, Oxaliplatin, and Docetaxel versus Fluorouracil or Capecitabine plus Cisplatin and Epirubicin for Locally Advanced, Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma (FLOT4): A Randomised, Phase 2/3 Trial. The Lancet, 393, 1948-1957. https://doi.org/10.1016/S0140-6736(18)32557-1
- Machado, M., Magalhaes, H. and Sousa, M. (2018) Perioperative Treatment in Gastric Cancer—Developments in Patient Selection. Journal of Cancer Therapy, 9, 101-105. https://doi.org/10.4236/jct.2018.92011
- Postmus, P.E., Kerr, K.M., Oudkerk, M., Senan, S., Waller, D.A., Vansteenkiste, J., Escriu, C. and Peters, S. (2017) Early-Stage and Locally Advanced (Non-Metastatic) Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines. Annals of Oncology, 28, iv1-iv21. https://doi.org/10.1093/annonc/mdx222
- Bass, A.J., et al. (2014) Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature, 513, 202-209. https://doi.org/10.1038/nature13480